NCT01768338 2023-02-10Recombinant Human IL-18 and Ofatumumab After PBSCT for LymphomaIndiana UniversityPhase 1 Completed9 enrolled
NCT02277392 2018-09-27A Phase-I, Dose Escalation Study of Recombinant Human Interleukin-18 (Sb-485232) Combined With Adoptive Transfer of Vaccine-Primed CD3/CD28-Costimulated Autologous T-Cells Following Lymphodepletion for Adult Patients With Recurrent Ovarian, Fallopian Tube or Primary Peritoneal CancerAbramson Cancer Center at Penn MedicinePhase 1 Withdrawn